{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T18:53:26Z","timestamp":1758394406182,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>In 2018, the first guideline-based quality indicators (QI) for vulvar cancer were implemented in the data-sheets of certified gynaecological cancer centres. The certification process includes guideline-based QIs as a fundamental component. These indicators are specifically designed to evaluate the level of care provided within the centres. This article aims to give an overview of the developing process of guideline based-QIs for women with vulvar cancer and presents the QIs results from the certified gynaecological cancer centres.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The QIs were derived in a standardized multiple step process during the update of the 2015 S2k guideline \u201cDiagnosis, Therapy, and Follow-Up Care of Vulvar Cancer and its Precursors\u201d (registry-number: no. 015\/059) and are based on strong recommendations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, there are eight guideline-based QIs for vulvar cancer. Four QIs are part of the certification process. In the treatment year 2021, 2.466 cases of vulvar cancer were treated in 177 centres. The target values in the centres for pathology reports on tumour resection and lymphadenectomy as well as sentinel lymph nodes have increased since the beginning of the certification process and have been above 90% over the past three treatment years (2019\u20132021).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>QIs based on strong guideline recommendations, play a crucial role in measuring and allowing to quantify essential aspects of patient care. By utilizing QIs, centres are able to identify areas for process optimization and draw informed conclusions. Over the years the quality of treatment of vulvar cancer patients measured by the QIs was improved. The certification system is continuously reviewed to enhance patient care even further by using the outcomes from QIs revaluation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-05769-4","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T13:01:59Z","timestamp":1715346119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Implementation of quality indicators for vulvar cancer in gynaecological cancer centres certified by the German Cancer Society (DKG)"],"prefix":"10.1007","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-2064","authenticated-orcid":false,"given":"Frederik A.","family":"Stuebs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Dannecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Nothacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Georg","family":"Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linn","family":"Woelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Wesselmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"issue":"2","key":"5769_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.6004\/jnccn.2024.0013","volume":"22","author":"NR Abu-Rustum","year":"2024","unstructured":"Abu-Rustum NR et al (2024) Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 22(2):117\u2013135","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"5769_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13643-017-0669-2","volume":"7","author":"M Becker","year":"2018","unstructured":"Becker M et al (2018) Guideline-based quality indicators\u2014a systematic comparison of German and international clinical practice guidelines: protocol for a systematic review. Syst Rev 7(1):5","journal-title":"Syst Rev"},{"issue":"7","key":"5769_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000329601","volume":"34","author":"MW Beckmann","year":"2011","unstructured":"Beckmann MW et al (2011) Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients. Onkologie 34(7):362\u2013367","journal-title":"Onkologie"},{"issue":"9","key":"5769_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1055\/s-0034-1383042","volume":"74","author":"MW Beckmann","year":"2014","unstructured":"Beckmann MW et al (2014) Establishment of the Certification System \u201cGynaecological Dysplasia\u201d in Germany. Geburtshilfe Frauenheilkd 74(9):860\u2013867","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"2","key":"5769_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/a-1671-2158","volume":"82","author":"MW Beckmann","year":"2022","unstructured":"Beckmann MW et al (2022) Diagnosis, therapy and follow-up of cervical cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032\/033OL, May 2021)\u2014part 1 with Recommendations on epidemiology, screening, Diagnostics and Therapy. Geburtshilfe Frauenheilkd 82(2):139\u2013180","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"5769_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00345-020-03411-9","volume":"39","author":"MC Butea-Bocu","year":"2021","unstructured":"Butea-Bocu MC et al (2021) Is there a clinical benefit from prostate cancer center certification? An evaluation of functional and oncologic outcomes from 22,649 radical prostatectomy patients. World J Urol 39(1):5\u201310","journal-title":"World J Urol"},{"key":"5769_CR7","unstructured":"Diagnosis, Therapy, and Follow-Up Care of Vulvar Cancer and its Precursors (2015) National Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015\/059, August 2015). https:\/\/register.awmf.org\/de\/leitlinien\/detail\/015-059. Accessed 25 Nov 2023"},{"issue":"2","key":"5769_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/a-1671-2446","volume":"82","author":"T Fehm","year":"2022","unstructured":"Fehm T et al (2022) Diagnosis, therapy and follow-up of cervical cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No.\u2009032\/033OL, May 2021)\u2014part 2 with recommendations on psycho-oncology, rehabilitation, follow-up, recurrence, palliative therapy and healthcare facilities. Geburtshilfe Frauenheilkd 82(2):181\u2013205","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5769_CR9","unstructured":"German Guideline Program in Oncology (German Cancer Society, German Cancer Aid, Association of the Scientific Medical Societies). Development of guidelinebased quality indicators: methodology for the German Guideline Program in Oncology, version 3.0. 2021 (2023). http:\/\/www.leitlinienprogrammonkologie.de\/methodik\/informationen-zur-methodik\/. Accessed 4 Jan 2023"},{"issue":"1","key":"5769_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/brainsci8010005","volume":"8","author":"A Haj","year":"2017","unstructured":"Haj A et al (2017) Extent of resection in newly diagnosed glioblastoma: impact of a specialized neuro-oncology care center. Brain Sci 8(1):5","journal-title":"Brain Sci"},{"key":"5769_CR11","unstructured":"Jahresbericht der deutschen Krebsgesellschaft (DKG)\u2014Gyn\u00e4kologische Krebszentren (2023). https:\/\/www.krebsgesellschaft.de\/jahresberichte.html. Accessed 2 Jan 2023"},{"key":"5769_CR12","unstructured":"Kennzahlenauswertung 2020\u2014Jahresbericht der zertifizierten Gyn\u00e4kologischen Krebszentren\u2014Auditjahr 2019\/Kennzahlenjahr 2018 (2020). https:\/\/www.krebsgesellschaft.de\/jahresberichte.html. Accessed 03 Dec 2023"},{"key":"5769_CR13","unstructured":"Kennzahlenauswertung 2021\u2014Jahresbericht der zertifizierten Gyn\u00e4kologischen Krebszentren\u2014Auditjahr 2020\/Kennzahlenjahr 2019 (2021). https:\/\/www.krebsgesellschaft.de\/jahresberichte.html. Accessed 3 Dec 2023"},{"key":"5769_CR14","unstructured":"Kennzahlenauswertung 2022\u2014Jahresbericht der zertifizierten Gyn\u00e4kologischen Krebszentren\u2014Auditjahr 2021\/Kennzahlenjahr 2020 (2022). https:\/\/www.onkozert.de\/wordpress\/wp-content\/uploads\/2022\/08\/qualitaetsindikatoren_gynaekologische-krebserkrankungen_2022-A1_220711.pdf?v=88676355. Accessed 7 Jan 2023"},{"key":"5769_CR15","unstructured":"Kennzahlenauswertung 2023\u2014Jahresbericht der zertifizierten Gyn\u00e4kologischen Krebszentren\u2014Auditjahr 2022\/Kennzahlenjahr 2021 (2023). https:\/\/www.krebsgesellschaft.de\/jahresberichte.html. Accessed 29 Nov 2023"},{"issue":"1","key":"5769_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1186\/s12885-017-3824-1","volume":"17","author":"C Kowalski","year":"2017","unstructured":"Kowalski C et al (2017) Shifting cancer care towards multidisciplinarity: the cancer center certification program of the German cancer society. BMC Cancer 17(1):850","journal-title":"BMC Cancer"},{"key":"5769_CR17","unstructured":"Krebs in Deutschland f\u00fcr 2019\/2020. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/krebs_in_deutschland_2023.pdf?__blob=publicationFile. Accessed 1 Mar 2024"},{"key":"5769_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.breast.2018.04.002","volume":"40","author":"R Kreienberg","year":"2018","unstructured":"Kreienberg R, W\u00f6ckel A, Wischnewsky M (2018) Highly significant improvement in guideline adherence, relapse-free and overall survival in breast cancer patients when treated at certified breast cancer centres: an evaluation of 8323 patients. Breast 40:54\u201359","journal-title":"Breast"},{"key":"5769_CR19","unstructured":"Kurzprotokoll zur Sitzung der Zertifizierungskommission Gyn\u00e4kologische Krebszentren_29.06.2017 (2017). https:\/\/www.krebsgesellschaft.de\/zertkomm-protokolle.html?file=files\/dkg\/deutsche-krebsgesellschaft\/content\/pdf\/Zertifizierung\/Protokolle_Zertkomm\/GZ_Protokoll_170629.pdf&cid=43707. Accessed 14 Jan 2023"},{"key":"5769_CR20","unstructured":"Kurzprotokoll zur Sitzung der Zertifizierungskommission Gyn\u00e4kologische Krebszentren_28.05.2019 (2019). https:\/\/www.krebsgesellschaft.de\/zertkomm-protokolle.html. Accessed 29 Nov 2023"},{"issue":"1","key":"5769_CR21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12913-020-05665-w","volume":"20","author":"MW Langendam","year":"2020","unstructured":"Langendam MW et al (2020) Approaches of integrating the development of guidelines and quality indicators: a systematic review. BMC Health Serv Res 20(1):875","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"5769_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.zefq.2010.07.003","volume":"105","author":"MJ Nothacker","year":"2011","unstructured":"Nothacker MJ, Langer T, Weinbrenner S (2011) Quality indicators for national disease management guidelines using the example of the National Disease Management Guideline for \u201cChronic Heart Failure.\u201d Z Evid Fortbild Qual Gesundhwes 105(1):27\u201337","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"5769_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13012-015-0369-z","volume":"11","author":"M Nothacker","year":"2016","unstructured":"Nothacker M et al (2016) Reporting standards for guideline-based performance measures. Implement Sci 11:6","journal-title":"Implement Sci"},{"issue":"7","key":"5769_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","volume":"33","author":"MHM Oonk","year":"2023","unstructured":"Oonk MHM et al (2023) European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer\u2014update 2023. Int J Gynecol Cancer 33(7):1023\u20131043","journal-title":"Int J Gynecol Cancer"},{"key":"5769_CR25","doi-asserted-by":"crossref","unstructured":"Onco Map (2024) https:\/\/www.oncomap.de\/centers?selectedOrgans=%5BGyn%C3%A4kologie%5D&showMap=1. Accessed 25 Mar 2024","DOI":"10.1109\/MMM.2023.3332337"},{"key":"5769_CR26","unstructured":"OnkoZert-Organspezifische Zentren-Brustkrebszentren (2024) https:\/\/www.onkozert.de\/organ\/brust\/. Accessed 23 Apr 2024"},{"issue":"4","key":"5769_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000517893","volume":"106","author":"J R\u00fcckher","year":"2022","unstructured":"R\u00fcckher J et al (2022) Guideline-based quality indicators for kidney and bladder cancer in Germany: development and implementation. Urol Int 106(4):360\u2013367","journal-title":"Urol Int"},{"issue":"39","key":"5769_CR28","first-page":"647","volume":"120","author":"J Schmitt","year":"2023","unstructured":"Schmitt J et al (2023) Initial cancer treatment in certified versus non-certified hospitals. Dtsch Arztebl Int 120(39):647\u2013654","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"5769_CR29","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1055\/a-1934-1686","volume":"83","author":"CE Schulmeyer","year":"2023","unstructured":"Schulmeyer CE et al (2023) Standardized procedures for patients with dysplasia and other diseases of the cervix, vulva, and vagina at a certified dysplasia unit prior to the introduction of the Organized Cervical Cancer Screening Program. Geburtshilfe Frauenheilkd 83(8):1031\u20131042","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"2","key":"5769_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ygyno.2020.02.026","volume":"157","author":"FA Stuebs","year":"2020","unstructured":"Stuebs FA et al (2020) Concordance rate of vulvoscopic findings in detecting early vulvar neoplasia. Gynecol Oncol 157(2):463\u2013468","journal-title":"Gynecol Oncol"},{"issue":"14","key":"5769_CR31","doi-asserted-by":"publisher","first-page":"12755","DOI":"10.1007\/s00432-023-05132-z","volume":"149","author":"FA Stuebs","year":"2023","unstructured":"Stuebs FA et al (2023) Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG). J Cancer Res Clin Oncol 149(14):12755\u201312764","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"5769_CR32","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.ejso.2018.05.013","volume":"44","author":"F Trautmann","year":"2018","unstructured":"Trautmann F et al (2018) Evidence-based quality standards improve prognosis in colon cancer care. Eur J Surg Oncol 44(9):1324\u20131330","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"5769_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00004347-198201000-00005","volume":"1","author":"EJ Wilkinson","year":"1982","unstructured":"Wilkinson EJ, Rico MJ, Pierson KK (1982) Microinvasive carcinoma of the vulva. Int J Gynecol Pathol 1(1):29\u201339","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"5769_CR34","doi-asserted-by":"publisher","first-page":"595.e1","DOI":"10.1016\/j.ajog.2020.12.1220","volume":"224","author":"L Woelber","year":"2021","unstructured":"Woelber L et al (2021) p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group. Am J Obstet Gynecol 224(6):595.e1-595.e11","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5769_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/LGT.0000000000000633","volume":"26","author":"J Zeitoun","year":"2022","unstructured":"Zeitoun J et al (2022) Impact of vulvar cancer surgery on quality of sex life: a review of literature. J Low Genit Tract Dis 26(1):38\u201342","journal-title":"J Low Genit Tract Dis"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05769-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05769-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05769-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:23:22Z","timestamp":1717989802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05769-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["5769"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05769-4","relation":{},"ISSN":["1432-1335"],"issn-type":[{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MF is Program Manager of the GGPO and supported the guideline group methodologically. All other authors declare they have no financial or other interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets generated during and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}}],"article-number":"250"}}